A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research.

Carragee EJ, Baker RM, Benzel EC, Bigos SJ, Cheng I, Corbin TP, Deyo RA, Hurwitz EL, Jarvik JG, Kang JD, Lurie JD, Mroz TE, Oner FC, Peul WC, Rainville J, Ratliff JK, Rihn JA, Rothman DJ, Schoene ML, Spengler DM, Weiner BK. A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research. Spine J. 2012 Oct; 12(10):877-80.

View in: PubMed

subject areas

Bone Morphogenetic Protein 2
Clinical Trials as Topic
Guidelines as Topic
Humans
Off-Label Use
Postoperative Complications
Recombinant Proteins
Spinal Fusion
Transforming Growth Factor beta

authors with profiles

Eric Hurwitz, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support